Linked Data API

Show Search Form

Search Results

224154
registered interest false more like this
date less than 2015-02-27more like thismore than 2015-02-27
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Epilepsy more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how much public money has been invested into development of new drugs and treatments for epilepsy in each of the last five years. more like this
tabling member constituency Leicester West remove filter
tabling member printed
Liz Kendall more like this
uin 225706 more like this
answer
answer
is ministerial correction false more like this
date of answer remove maximum value filtermore like thismore than 2015-03-04
answer text <p>The following table shows estimated expenditure on epilepsy research and development by the National Institute for Health (NIHR) through its research programmes, research centres and units and research fellowships.</p><p> </p><p> </p><p> </p><p><em>£ million</em></p><p> </p><table><tbody><tr><td><p> </p></td><td><p>2009/10</p></td><td><p>2010/11</p></td><td><p>2011/12</p></td><td><p>2012/13</p></td><td><p>2013/14</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.8</p></td><td><p>1.0</p></td><td><p>1.3</p></td><td><p>2.7</p></td><td><p>3.1</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>Total spend by the NIHR on epilepsy is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on this condition cannot be disaggregated from total CRN expenditure.</p><p> </p><p> </p><p> </p><p>The following table shows estimated expenditure on research on epilepsy by the Research Councils and Innovate UK.</p><p> </p><p> </p><p> </p><p><em>£ million</em></p><p> </p><table><tbody><tr><td><p> </p></td><td><p>2009/10</p></td><td><p>2010/11</p></td><td><p>2011/12</p></td><td><p>2012/13</p></td><td><p>2013/14</p></td></tr><tr><td><p>Research Councils and Innovate UK</p></td><td><p>4.2</p></td><td><p>3.5</p></td><td><p>2.0</p></td><td><p>2.3</p></td><td><p>3.1</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>In addition to research directly relating to epilepsy, the Medical Research Council also supports a broad portfolio of research that aims to improve our understanding of the underlying mechanisms of neuroscience and neurological conditions including epilepsy.</p><p> </p><p> </p><p> </p><p>The following table shows estimated expenditure on development of new drugs and treatments for epilepsy by the Research Councils and Innovate UK.</p><p> </p><p> </p><p> </p><p><em>£ million</em></p><p> </p><table><tbody><tr><td><p> </p></td><td><p>2009/10</p></td><td><p>2010/11</p></td><td><p>2011/12</p></td><td><p>2012/13</p></td><td><p>2013/14</p></td></tr><tr><td><p>Research Councils and Innovate UK</p></td><td><p>0.1</p></td><td><p>0.2</p></td><td><p>0.3</p></td><td><p>0.3</p></td><td><p>0.4</p></td></tr></tbody></table><p> </p><p> </p><p> </p>
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
grouped question UIN 225699 more like this
question first answered
less than 2015-03-04T17:25:17.93Zmore like thismore than 2015-03-04T17:25:17.93Z
answering member
4020
label Biography information for George Freeman remove filter
tabling member
4026
label Biography information for Liz Kendall more like this
224161
registered interest false more like this
date less than 2015-02-27more like thismore than 2015-02-27
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Epilepsy more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how much public money has been granted into research into epilepsy in each of the last five years. more like this
tabling member constituency Leicester West remove filter
tabling member printed
Liz Kendall more like this
uin 225699 more like this
answer
answer
is ministerial correction false more like this
date of answer remove maximum value filtermore like thismore than 2015-03-04
answer text <p>The following table shows estimated expenditure on epilepsy research and development by the National Institute for Health (NIHR) through its research programmes, research centres and units and research fellowships.</p><p> </p><p> </p><p> </p><p><em>£ million</em></p><p> </p><table><tbody><tr><td><p> </p></td><td><p>2009/10</p></td><td><p>2010/11</p></td><td><p>2011/12</p></td><td><p>2012/13</p></td><td><p>2013/14</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.8</p></td><td><p>1.0</p></td><td><p>1.3</p></td><td><p>2.7</p></td><td><p>3.1</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>Total spend by the NIHR on epilepsy is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on this condition cannot be disaggregated from total CRN expenditure.</p><p> </p><p> </p><p> </p><p>The following table shows estimated expenditure on research on epilepsy by the Research Councils and Innovate UK.</p><p> </p><p> </p><p> </p><p><em>£ million</em></p><p> </p><table><tbody><tr><td><p> </p></td><td><p>2009/10</p></td><td><p>2010/11</p></td><td><p>2011/12</p></td><td><p>2012/13</p></td><td><p>2013/14</p></td></tr><tr><td><p>Research Councils and Innovate UK</p></td><td><p>4.2</p></td><td><p>3.5</p></td><td><p>2.0</p></td><td><p>2.3</p></td><td><p>3.1</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>In addition to research directly relating to epilepsy, the Medical Research Council also supports a broad portfolio of research that aims to improve our understanding of the underlying mechanisms of neuroscience and neurological conditions including epilepsy.</p><p> </p><p> </p><p> </p><p>The following table shows estimated expenditure on development of new drugs and treatments for epilepsy by the Research Councils and Innovate UK.</p><p> </p><p> </p><p> </p><p><em>£ million</em></p><p> </p><table><tbody><tr><td><p> </p></td><td><p>2009/10</p></td><td><p>2010/11</p></td><td><p>2011/12</p></td><td><p>2012/13</p></td><td><p>2013/14</p></td></tr><tr><td><p>Research Councils and Innovate UK</p></td><td><p>0.1</p></td><td><p>0.2</p></td><td><p>0.3</p></td><td><p>0.3</p></td><td><p>0.4</p></td></tr></tbody></table><p> </p><p> </p><p> </p>
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
grouped question UIN 225706 more like this
question first answered
less than 2015-03-04T17:25:17.467Zmore like thismore than 2015-03-04T17:25:17.467Z
answering member
4020
label Biography information for George Freeman remove filter
tabling member
4026
label Biography information for Liz Kendall more like this
224163
registered interest false more like this
date less than 2015-02-27more like thismore than 2015-02-27
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Epilepsy more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how much money has been spent on the prescription of drugs to manage epilepsy in the NHS in each of the last five years. more like this
tabling member constituency Leicester West remove filter
tabling member printed
Liz Kendall more like this
uin 225701 more like this
answer
answer
is ministerial correction false more like this
date of answer remove maximum value filtermore like thismore than 2015-03-04
answer text <p>Information on the cost of medicines to treat epilepsy is shown in the table.</p><p> </p><p> </p><p> </p><table><tbody><tr><td colspan="3"><p>Net Ingredient Cost of medicines dispensed in England to treat epilepsy, as defined by British National Formulary (BNF) Section 4.8.1 <em>Control of the epilepsies</em> and 4.8.2 <em>Drugs used in status epilepticus</em>.</p></td></tr><tr><td><p> </p></td><td><p>Primary care cost (£)</p></td><td><p>Secondary care cost (£)</p></td></tr><tr><td><p>2014/15 Q1 only</p></td><td><p>117,954,639</p></td><td><p>8,972,447</p></td></tr><tr><td><p>2013/14</p></td><td><p>455,561,100</p></td><td><p>33,557,584</p></td></tr><tr><td><p>2012/13</p></td><td><p>397,626,888</p></td><td><p>29,691,830</p></td></tr><tr><td><p>2011/12</p></td><td><p>382,640,431</p></td><td><p>27,282,775</p></td></tr><tr><td><p>2010/11</p></td><td><p>346,221,736</p></td><td><p>25,390,620</p></td></tr><tr><td><p>2009/10</p></td><td><p>304,583,390</p></td><td><p>23,954,258</p></td></tr></tbody></table><p> </p><p><em>Source: </em></p><p> </p><p>Prescription Cost Analysis (PCA) provided by the Health and Social Care Information Centre (primary care)</p><p> </p><p>Hospital Pharmacy Audit Index (HPAI) provided by IMS Health (secondary care)</p><p> </p><p><em> </em></p><p> </p><p><em>Notes:</em></p><p> </p><p>Net Ingredient Cost (NIC)</p><p> </p><p>NIC is the basic cost of a drug. It does not take account of discounts, dispensing costs, fees or prescription charges income.</p><p> </p><p>BNF Classifications</p><p> </p><p>The PCA system uses the therapeutic classifications defined in the BNF. Information on why a drug is prescribed is not available in this dataset. Since drugs can be prescribed to treat more than one condition, it may not be possible to separate the different conditions for which a drug may have been prescribed.</p><p> </p><p> </p><p> </p>
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
question first answered
less than 2015-03-04T17:27:59.743Zmore like thismore than 2015-03-04T17:27:59.743Z
answering member
4020
label Biography information for George Freeman remove filter
tabling member
4026
label Biography information for Liz Kendall more like this
223289
registered interest false more like this
date less than 2015-02-24more like thismore than 2015-02-24
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Asthma: Medical Equipment more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how many patients in England have been prescribed more than 12 short-acting reliever inhalers in each of the last five years. more like this
tabling member constituency Leicester West remove filter
tabling member printed
Liz Kendall more like this
uin 225239 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-02-27more like thismore than 2015-02-27
answer text <p>Information is not collected centrally on the numbers of prescriptions issued, the number of people prescribed medicines or the medical condition being treated. However, information is available on the number of prescription items dispensed in the community in England. This is attached.</p><p> </p> more like this
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
grouped question UIN
225234 more like this
225247 more like this
225263 more like this
question first answered
less than 2015-02-27T12:03:59.247Zmore like thismore than 2015-02-27T12:03:59.247Z
answering member
4020
label Biography information for George Freeman remove filter
attachment
1
file name Prescription item - analysis table.docx more like this
title Asthma medicine prescription items more like this
tabling member
4026
label Biography information for Liz Kendall more like this
223299
registered interest false more like this
date less than 2015-02-24more like thismore than 2015-02-24
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Asthma: Medical Equipment more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how many asthma patients in England have been prescribed short-acting reliever inhalers in each of the last five years. more like this
tabling member constituency Leicester West remove filter
tabling member printed
Liz Kendall more like this
uin 225234 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-02-27more like thismore than 2015-02-27
answer text <p>Information is not collected centrally on the numbers of prescriptions issued, the number of people prescribed medicines or the medical condition being treated. However, information is available on the number of prescription items dispensed in the community in England. This is attached.</p><p> </p> more like this
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
grouped question UIN
225239 more like this
225247 more like this
225263 more like this
question first answered
less than 2015-02-27T12:03:58.847Zmore like thismore than 2015-02-27T12:03:58.847Z
answering member
4020
label Biography information for George Freeman remove filter
attachment
1
file name Prescription item - analysis table.docx more like this
title Asthma medicine prescription items more like this
tabling member
4026
label Biography information for Liz Kendall more like this
223306
registered interest false more like this
date less than 2015-02-24more like thismore than 2015-02-24
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Asthma more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how many prescriptions for asthma medications were issued in each of the last five years. more like this
tabling member constituency Leicester West remove filter
tabling member printed
Liz Kendall more like this
uin 225247 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-02-27more like thismore than 2015-02-27
answer text <p>Information is not collected centrally on the numbers of prescriptions issued, the number of people prescribed medicines or the medical condition being treated. However, information is available on the number of prescription items dispensed in the community in England. This is attached.</p><p> </p> more like this
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
grouped question UIN
225234 more like this
225239 more like this
225263 more like this
question first answered
less than 2015-02-27T12:03:59.37Zmore like thismore than 2015-02-27T12:03:59.37Z
answering member
4020
label Biography information for George Freeman remove filter
attachment
1
file name Prescription item - analysis table.docx more like this
title Asthma medicine prescription items more like this
tabling member
4026
label Biography information for Liz Kendall more like this
223308
registered interest false more like this
date less than 2015-02-24more like thismore than 2015-02-24
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Asthma: Medical Equipment more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how many short-acting reliever inhalers for the treatment of asthma have been prescribed in each of the last five years. more like this
tabling member constituency Leicester West remove filter
tabling member printed
Liz Kendall more like this
uin 225263 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-02-27more like thismore than 2015-02-27
answer text <p>Information is not collected centrally on the numbers of prescriptions issued, the number of people prescribed medicines or the medical condition being treated. However, information is available on the number of prescription items dispensed in the community in England. This is attached.</p><p> </p> more like this
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
grouped question UIN
225234 more like this
225239 more like this
225247 more like this
question first answered
less than 2015-02-27T12:03:59.51Zmore like thismore than 2015-02-27T12:03:59.51Z
answering member
4020
label Biography information for George Freeman remove filter
attachment
1
file name Prescription item - analysis table.docx more like this
title Asthma medicine prescription items more like this
tabling member
4026
label Biography information for Liz Kendall more like this
100876
registered interest false more like this
date less than 2014-10-24more like thismore than 2014-10-24
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Asthma: Drugs more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how much has been spent on the prescription of asthma drugs in the NHS in each of the last five years. more like this
tabling member constituency Leicester West remove filter
tabling member printed
Liz Kendall more like this
uin 211846 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-10-29more like thismore than 2014-10-29
answer text <p>Information on National Health Service expenditure on drugs for the treatment of asthma in primary and secondary care is in the table.</p><p> </p><p><strong> </strong></p><p> </p><p>Drugs for the treatment of osteoporosis have been defined as those included in the following British National Formulary sections:</p><p> </p><p>3.1.1 Adrenoceptor agonists</p><p> </p><p>3.1.2 Antimuscarinic bronchodilators</p><p> </p><p>3.1.3 Theophylline</p><p> </p><p>3.2 Corticosteroids</p><p> </p><p>3.3.1 Cromoglicate and related therapy</p><p> </p><p>3.3.2 Leukotriene receptor antagonists</p><p> </p><p>3.4.2 Allergen immunotherapy (omalizumab only)</p><p> </p><p> </p><p> </p><table><tbody><tr><td colspan="11"><p>Cost of drugs for the treatment of asthma, England<sup>1</sup></p></td></tr><tr><td rowspan="2"><p>Drug name</p></td><td colspan="5"><p>Primary Care (£ millions)</p></td><td colspan="5"><p>Secondary Care (£ millions)</p></td></tr><tr><td><p>2009</p></td><td><p>2010</p></td><td><p>2011</p></td><td><p>2012</p></td><td><p>2013</p></td><td><p>2009</p></td><td><p>2010</p></td><td><p>2011</p></td><td><p>2012</p></td><td><p>2013</p></td></tr><tr><td><p>Aclidinium Bromide</p></td><td><p>-</p></td><td><p>-</p></td><td><p>-</p></td><td><p>0.02</p></td><td><p>1.62</p></td><td><p>-</p></td><td><p>-</p></td><td><p>-</p></td><td><p>0.00</p></td><td><p>0.03</p></td></tr><tr><td><p>Aminophylline</p></td><td><p>1.25</p></td><td><p>1.18</p></td><td><p>1.12</p></td><td><p>1.08</p></td><td><p>1.05</p></td><td><p>0.30</p></td><td><p>0.29</p></td><td><p>0.21</p></td><td><p>0.23</p></td><td><p>0.22</p></td></tr><tr><td><p>Beclometasone Dipropionate</p></td><td><p>84.26</p></td><td><p>87.72</p></td><td><p>90.30</p></td><td><p>97.56</p></td><td><p>102.39</p></td><td><p>1.62</p></td><td><p>1.53</p></td><td><p>1.41</p></td><td><p>1.49</p></td><td><p>1.42</p></td></tr><tr><td><p>Budesonide</p></td><td><p>140.35</p></td><td><p>149.03</p></td><td><p>158.82</p></td><td><p>169.14</p></td><td><p>177.00</p></td><td><p>1.29</p></td><td><p>1.14</p></td><td><p>1.14</p></td><td><p>1.27</p></td><td><p>1.41</p></td></tr><tr><td><p>Budesonide/ Formoterol</p></td><td><p>-</p></td><td><p>-</p></td><td><p>-</p></td><td><p>-</p></td><td><p>-</p></td><td><p>2.75</p></td><td><p>2.94</p></td><td><p>2.89</p></td><td><p>3.10</p></td><td><p>3.29</p></td></tr><tr><td><p>Ciclesonide</p></td><td><p>0.84</p></td><td><p>0.95</p></td><td><p>1.03</p></td><td><p>1.12</p></td><td><p>1.25</p></td><td><p>0.01</p></td><td><p>0.02</p></td><td><p>0.02</p></td><td><p>0.02</p></td><td><p>0.03</p></td></tr><tr><td><p>Fluticasone</p></td><td><p>366.24</p></td><td><p>380.56</p></td><td><p>387.89</p></td><td><p>392.95</p></td><td><p>396.10</p></td><td><p>1.00</p></td><td><p>0.93</p></td><td><p>0.91</p></td><td><p>1.00</p></td><td><p>0.99</p></td></tr><tr><td><p>Fluticasone/ Salmeterol</p></td><td><p>-</p></td><td><p>-</p></td><td><p>-</p></td><td><p>-</p></td><td><p>-</p></td><td><p>11.46</p></td><td><p>11.56</p></td><td><p>10.69</p></td><td><p>10.82</p></td><td><p>10.48</p></td></tr><tr><td><p>Formoterol Fumarate</p></td><td><p>5.18</p></td><td><p>4.87</p></td><td><p>4.68</p></td><td><p>4.85</p></td><td><p>4.93</p></td><td><p>0.10</p></td><td><p>0.08</p></td><td><p>0.07</p></td><td><p>0.06</p></td><td><p>0.06</p></td></tr><tr><td><p>Glycopyrronium Bromide</p></td><td><p>-</p></td><td><p>-</p></td><td><p>-</p></td><td><p>0.01</p></td><td><p>2.30</p></td><td><p>0.58</p></td><td><p>0.62</p></td><td><p>0.70</p></td><td><p>0.79</p></td><td><p>1.00</p></td></tr><tr><td><p>Indacaterol Maleate</p></td><td><p>-</p></td><td><p>0.04</p></td><td><p>0.30</p></td><td><p>0.92</p></td><td><p>1.47</p></td><td><p>-</p></td><td><p>0.00</p></td><td><p>0.00</p></td><td><p>0.02</p></td><td><p>0.04</p></td></tr><tr><td><p>Ipratropium Bromide</p></td><td><p>16.15</p></td><td><p>15.02</p></td><td><p>13.74</p></td><td><p>10.32</p></td><td><p>8.61</p></td><td><p>2.74</p></td><td><p>2.84</p></td><td><p>2.59</p></td><td><p>2.65</p></td><td><p>2.70</p></td></tr><tr><td><p>Mometasone Furoate</p></td><td><p>0.36</p></td><td><p>0.31</p></td><td><p>0.26</p></td><td><p>0.23</p></td><td><p>0.21</p></td><td><p>0.76</p></td><td><p>0.71</p></td><td><p>0.61</p></td><td><p>0.63</p></td><td><p>0.67</p></td></tr><tr><td><p>Montelukast</p></td><td><p>38.91</p></td><td><p>43.01</p></td><td><p>46.96</p></td><td><p>51.71</p></td><td><p>31.31</p></td><td><p>0.98</p></td><td><p>1.02</p></td><td><p>1.03</p></td><td><p>1.16</p></td><td><p>0.81</p></td></tr><tr><td><p>Omalizumab</p></td><td><p>0.00</p></td><td><p>0.01</p></td><td><p>0.03</p></td><td><p>0.15</p></td><td><p>0.12</p></td><td><p>5.97</p></td><td><p>9.22</p></td><td><p>12.16</p></td><td><p>14.65</p></td><td><p>17.86</p></td></tr><tr><td><p>Salbutamol</p></td><td><p>83.15</p></td><td><p>82.64</p></td><td><p>60.58</p></td><td><p>60.37</p></td><td><p>59.95</p></td><td><p>3.78</p></td><td><p>3.77</p></td><td><p>3.36</p></td><td><p>3.38</p></td><td><p>3.29</p></td></tr><tr><td><p>Salmeterol</p></td><td><p>48.80</p></td><td><p>45.16</p></td><td><p>41.87</p></td><td><p>36.72</p></td><td><p>34.04</p></td><td><p>0.87</p></td><td><p>0.74</p></td><td><p>0.59</p></td><td><p>0.53</p></td><td><p>0.47</p></td></tr><tr><td><p>Terbutaline Sulphate</p></td><td><p>8.61</p></td><td><p>8.20</p></td><td><p>7.61</p></td><td><p>7.43</p></td><td><p>7.18</p></td><td><p>0.18</p></td><td><p>0.16</p></td><td><p>0.14</p></td><td><p>0.14</p></td><td><p>0.15</p></td></tr><tr><td><p>Theophylline</p></td><td><p>2.18</p></td><td><p>2.17</p></td><td><p>2.15</p></td><td><p>2.22</p></td><td><p>2.26</p></td><td><p>0.12</p></td><td><p>0.11</p></td><td><p>0.11</p></td><td><p>0.11</p></td><td><p>0.11</p></td></tr><tr><td><p>Tiotropium</p></td><td><p>113.61</p></td><td><p>129.98</p></td><td><p>149.81</p></td><td><p>169.35</p></td><td><p>185.24</p></td><td><p>5.69</p></td><td><p>6.03</p></td><td><p>6.22</p></td><td><p>6.64</p></td><td><p>6.87</p></td></tr><tr><td><p>Zafirlukast</p></td><td><p>0.79</p></td><td><p>0.71</p></td><td><p>0.71</p></td><td><p>0.70</p></td><td><p>0.69</p></td><td><p>0.01</p></td><td><p>0.01</p></td><td><p>0.01</p></td><td><p>0.01</p></td><td><p>0.01</p></td></tr><tr><td><p>Other drugs<sup>2</sup></p></td><td><p>0.90</p></td><td><p>0.79</p></td><td><p>0.66</p></td><td><p>0.62</p></td><td><p>0.60</p></td><td><p>0.04</p></td><td><p>0.07</p></td><td><p>0.15</p></td><td><p>0.26</p></td><td><p>0.46</p></td></tr><tr><td><p>Total</p></td><td><p>911.6</p></td><td><p>952.3</p></td><td><p>968.5</p></td><td><p>1,007.5</p></td><td><p>1,018.3</p></td><td><p>40.3</p></td><td><p>43.8</p></td><td><p>45.0</p></td><td><p>49.0</p></td><td><p>52.4</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p><sup>1 </sup>Cost of drugs at NHS list price not taking account of discounts, dispensing costs, fees or prescription charges income. Totals may not add up due to rounding.</p><p> </p><p><sup>2</sup> Other drugs include Azelastine/Fluticasone, Bambuterol Hydrochloride, Beclometasone/ Formoterol, Cromoglicic Acid, Fenoterol Hydrobromide, Fenoterol/Ipratropium Bromide, Fluticasone/ Formoterol, Nedocromil Sodium, Orciprenaline Sulfate and Sodium Cromoglicate.</p><p> </p><p>Source:</p><p> </p><p>Prescription Cost Analysis (PCA) provided by the Health and Social Care Information Centre (primary care)</p><p> </p><p>Hospital Pharmacy Audit Index (HPAI) provided by IMS Health (secondary care)</p><p> </p><p> </p><p> </p><p>Since some drugs are prescribed to treat more than one condition and as the condition for which a drug is prescribed is not collected, it is not possible to separate the different conditions for which a drug may have been prescribed. The information provided may therefore include costs from the prescribing of these drugs for conditions other than for asthma.</p><p> </p>
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
question first answered
less than 2014-10-29T17:13:01.0657405Zmore like thismore than 2014-10-29T17:13:01.0657405Z
answering member
4020
label Biography information for George Freeman remove filter
tabling member
4026
label Biography information for Liz Kendall more like this
100885
registered interest false more like this
date less than 2014-10-24more like thismore than 2014-10-24
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Asthma: Drugs more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how much the Government has spent on the development of new drugs to treat the symptoms of asthma in each of the last five years. more like this
tabling member constituency Leicester West remove filter
tabling member printed
Liz Kendall more like this
uin 211885 more like this
answer
answer
is ministerial correction true more like this
date of answer less than 2014-10-29more like thismore than 2014-10-29
answer text <p>The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.</p><p> </p><p> </p><p> </p><p><em>£ million</em></p><p> </p><table><tbody><tr><td> </td><td><p>2009-10</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td><td><p>2013-14</p></td></tr><tr><td colspan="6"><p>Asthma</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p><del class="ministerial">22.2 </del><ins class="ministerial">6.6</ins></p></td><td><p><del class="ministerial">17.5 </del><ins class="ministerial">5.3</ins></p></td><td><p><del class="ministerial">17.2</del><ins class="ministerial"> 4.5</ins></p></td><td><p><del class="ministerial">19.4</del><ins class="ministerial"> 3.6</ins></p></td><td><p><del class="ministerial">18.8</del><ins class="ministerial"> 5.4</ins></p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.3</p></td><td><p>1.5</p></td><td><p>0.8</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>2.6</p></td><td><p>3.4</p></td><td><p>2.4</p></td><td><p>3.4</p></td><td><p>3.8</p></td></tr><tr><td><p>Total</p></td><td><p><del class="ministerial">24.8</del><ins class="ministerial"> 9.2</ins></p></td><td><p><del class="ministerial">21.0</del><ins class="ministerial"> 8.8</ins></p></td><td><p><del class="ministerial">19.9</del><ins class="ministerial"> 7.2</ins></p></td><td><p><del class="ministerial">24.3 </del><ins class="ministerial">8.5</ins></p></td><td><p><del class="ministerial">23.4</del> <ins class="ministerial">10.0</ins></p></td></tr><tr><td colspan="6"><p>Motor Neurone Research</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>7.0</p></td><td><p>7.5</p></td><td><p>4.2</p></td><td><p>4.1</p></td><td><p>3.6</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.2</p></td><td><p>0.2</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.1</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>0.5</p></td></tr><tr><td><p>Total</p></td><td><p>7.3</p></td><td><p>7.8</p></td><td><p>5.0</p></td><td><p>5.5</p></td><td><p>5.1</p></td></tr><tr><td colspan="6"><p>Osteoporosis</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>6.2</p></td><td><p>5.4</p></td><td><p>5.1</p></td><td><p>4.6</p></td><td><p>5.9</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.3</p></td><td><p>0.7</p></td><td><p>0.8</p></td><td><p>1.3</p></td><td><p>1.8</p></td></tr><tr><td><p>Total</p></td><td><p>6.5</p></td><td><p>6.1</p></td><td><p>6.0</p></td><td><p>6.3</p></td><td><p>8.7</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.</p><p> </p><p> </p><p> </p><p>Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.</p><p> </p><p> </p><p> </p><p>Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.</p><p> </p>
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
question first answered
less than 2014-10-29T17:12:29.113Zmore like thismore than 2014-10-29T17:12:29.113Z
question first ministerially corrected
less than 2014-11-13T10:22:56.0372213Zmore like thismore than 2014-11-13T10:22:56.0372213Z
answering member
4020
label Biography information for George Freeman remove filter
previous answer version
25123
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
answering member
4020
label Biography information for George Freeman more like this
tabling member
4026
label Biography information for Liz Kendall more like this
100887
registered interest false more like this
date less than 2014-10-24more like thismore than 2014-10-24
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Asthma more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how much public funding was allocated to research into asthma in each of the last five years. more like this
tabling member constituency Leicester West remove filter
tabling member printed
Liz Kendall more like this
uin 211918 more like this
answer
answer
is ministerial correction true more like this
date of answer less than 2014-10-29more like thismore than 2014-10-29
answer text <p>The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.</p><p> </p><p> </p><p> </p><p><em>£ million</em></p><p> </p><table><tbody><tr><td> </td><td><p>2009-10</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td><td><p>2013-14</p></td></tr><tr><td colspan="6"><p>Asthma</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p><del class="ministerial">22.2 </del><ins class="ministerial">6.6</ins></p></td><td><p><del class="ministerial">17.5 </del><ins class="ministerial">5.3</ins></p></td><td><p><del class="ministerial">17.2</del><ins class="ministerial"> 4.5</ins></p></td><td><p><del class="ministerial">19.4</del><ins class="ministerial"> 3.6</ins></p></td><td><p><del class="ministerial">18.8</del><ins class="ministerial"> 5.4</ins></p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.3</p></td><td><p>1.5</p></td><td><p>0.8</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>2.6</p></td><td><p>3.4</p></td><td><p>2.4</p></td><td><p>3.4</p></td><td><p>3.8</p></td></tr><tr><td><p>Total</p></td><td><p><del class="ministerial">24.8</del><ins class="ministerial"> 9.2</ins></p></td><td><p><del class="ministerial">21.0</del><ins class="ministerial"> 8.8</ins></p></td><td><p><del class="ministerial">19.9</del><ins class="ministerial"> 7.2</ins></p></td><td><p><del class="ministerial">24.3 </del><ins class="ministerial">8.5</ins></p></td><td><p><del class="ministerial">23.4</del> <ins class="ministerial">10.0</ins></p></td></tr><tr><td colspan="6"><p>Motor Neurone Research</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>7.0</p></td><td><p>7.5</p></td><td><p>4.2</p></td><td><p>4.1</p></td><td><p>3.6</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.2</p></td><td><p>0.2</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.1</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>0.5</p></td></tr><tr><td><p>Total</p></td><td><p>7.3</p></td><td><p>7.8</p></td><td><p>5.0</p></td><td><p>5.5</p></td><td><p>5.1</p></td></tr><tr><td colspan="6"><p>Osteoporosis</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>6.2</p></td><td><p>5.4</p></td><td><p>5.1</p></td><td><p>4.6</p></td><td><p>5.9</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.3</p></td><td><p>0.7</p></td><td><p>0.8</p></td><td><p>1.3</p></td><td><p>1.8</p></td></tr><tr><td><p>Total</p></td><td><p>6.5</p></td><td><p>6.1</p></td><td><p>6.0</p></td><td><p>6.3</p></td><td><p>8.7</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.</p><p> </p><p> </p><p> </p><p>Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.</p><p> </p><p> </p><p> </p><p>Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.</p><p> </p>
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
question first answered
less than 2014-10-29T17:12:28.3318918Zmore like thismore than 2014-10-29T17:12:28.3318918Z
question first ministerially corrected
less than 2014-11-13T10:22:56.0372213Zmore like thismore than 2014-11-13T10:22:56.0372213Z
answering member
4020
label Biography information for George Freeman remove filter
previous answer version
25123
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
answering member
4020
label Biography information for George Freeman more like this
tabling member
4026
label Biography information for Liz Kendall more like this